PROTAC small-molecule degraders of MDM2 protein

被引：0
|
作者：
Aguilar, A. [1 ,2 ]
Yang, J. [1 ,3 ]
Li, Y. [1 ,2 ,4 ]
McEachern, D. [1 ,2 ]
Przybranowski, S. [1 ,2 ]
Liu, L. [1 ,2 ]
Yang, C. Y. [1 ,2 ]
Wang, S. [1 ,2 ,4 ]
机构：
[1] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Pharmacol & Internal Med, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
279 (PB-04
引用
收藏
页码：E94 / E94
页数：1
相关论文
共 50 条
  • [1] Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy:advances and perspectives
    Yuan Fang
    Guochao Liao
    Bin Yu
    ActaPharmaceuticaSinicaB, 2020, 10 (07) : 1253 - 1278
  • [2] Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
    Fang, Yuan
    Liao, Guochao
    Yu, Bin
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (07) : 1253 - 1278
  • [3] PROTAC small-molecule degraders of AR protein
    Han, Xin
    Wang, Chao
    Qin, Chong
    Xiang, Weiguo
    Fernandez-Salas, Ester
    Yang, Chao-Yie
    Wang, Mi
    Zhao, Lijie
    Xu, Tianfeng
    Stuckey, Jeanne
    Wang, Shaomeng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [4] Development of selective small molecule MDM2 degraders based on nutlin
    Wang, Bo
    Wu, Suzhen
    Liu, Jin
    Yang, Ka
    Xie, Haibo
    Tang, Weiping
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 176 : 476 - 491
  • [5] Small-molecule inhibitors of MDM2 as new anticancer therapeutics
    Dickens, Michael P.
    Fitzgerald, Ross
    Fischer, Peter M.
    SEMINARS IN CANCER BIOLOGY, 2010, 20 (01) : 10 - 18
  • [6] PROTAC design of Mdm2 degraders: A novel efficient approach for cancer therapy
    Li, Yangbing
    Yang, Jiuling
    Aguilar, Angelo
    Lu, Jianfeng
    McEachern, Donna
    Bernard, Denzil
    Wang, Shaomeng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [7] Design of orally bioavailable proteolysis targeting chimera (PROTAC) small-molecule degraders
    Wang, Shaomeng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [8] Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders
    Yang, Jiuling
    Li, Yangbing
    Aguilar, Angelo
    Liu, Zhaomin
    Yang, Chao-Yie
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (21) : 9471 - 9487
  • [9] Small-molecule MDM2 inhibitors in clinical trials for cancer therapy
    Wang, Shuai
    Chen, Fen-Er
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 236
  • [10] Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma
    Van Maerken, Tom
    Speleman, Frank
    Vermeulen, Joelle
    Lambertz, Irina
    De Clercq, Sarah
    De Smet, Els
    Yigit, Nurten
    Coppens, Vicky
    Philippe, Jan
    De Paepe, Anne
    Marine, Jean-Christophe
    Vandesompele, Jo
    CANCER RESEARCH, 2006, 66 (19) : 9646 - 9655
12345